Related Experiment Video
Updated: May 23, 2026
06:38
Detection of Abnormal Prion Protein by Immunohistochemistry
Published on: May 5, 2023
Imaging of prion diseases
Laurent Letourneau-Guillon1, Ryan Wada, Walter Kucharczyk
1Department of Diagnostic Imaging, University Health Network, University of Toronto, Toronto, Ontario, Canada. laurent_letg@hotmail.com
Journal of Magnetic Resonance Imaging : JMRI
|April 14, 2012
Summary
Neuroimaging, particularly MRI, has greatly improved the diagnosis of prion diseases, a group of fatal neurodegenerative disorders caused by self-replicating proteins. Advances in techniques like diffusion-weighted imaging aid in detecting these complex brain conditions.
Area of Science:
- Neurology
- Radiology
- Molecular Biology
Background:
- Prion diseases are fatal neurodegenerative disorders caused by misfolded proteins.
- Understanding of prion disease phenotypes has advanced with molecular biology.
- Neuroimaging plays a crucial role in diagnosing these conditions.
Purpose of the Study:
- To review the neuroimaging features of human prion disorders.
- To highlight the diagnostic contribution of MRI in prion diseases.
- To discuss advancements in imaging techniques for prion disease detection.
Main Methods:
- Review of neuroimaging findings in human prion diseases.
- Emphasis on Magnetic Resonance Imaging (MRI) techniques.
- Discussion of diffusion-weighted imaging (DWI) and other advanced methods.
Main Results:
- Diffusion-weighted imaging (DWI) has significantly improved prion disease detection, especially Creutzfeldt-Jakob disease.
- Advanced imaging techniques like quantitative DWI and MR spectroscopy show promise for less common genetic prion disorders.
- MRI is a key tool in the diagnostic process for prion-related disorders.
Conclusions:
- Neuroimaging, particularly MRI, is essential for diagnosing prion diseases.
- Technological advancements continue to enhance the detection and characterization of prion disorders.
- Continued research in neuroimaging will further aid in understanding and managing these neurodegenerative conditions.
Related Concept Videos
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:14Brain Imaging
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic Stimulation (TMS).
01:25Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET